Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 52% ± 25% | |
astrocyte | 10 studies | 29% ± 11% | |
endothelial cell | 10 studies | 30% ± 10% | |
T cell | 5 studies | 22% ± 2% | |
GABAergic neuron | 5 studies | 58% ± 12% | |
natural killer cell | 4 studies | 21% ± 1% | |
interneuron | 4 studies | 50% ± 18% | |
CD4-positive, alpha-beta T cell | 3 studies | 23% ± 2% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
mast cell | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 30% ± 7% | |
retinal cone cell | 3 studies | 23% ± 6% | |
retinal rod cell | 3 studies | 20% ± 3% | |
CD8-positive, alpha-beta T cell | 3 studies | 22% ± 1% | |
macrophage | 3 studies | 21% ± 4% | |
lymphocyte | 3 studies | 41% ± 16% | |
granule cell | 3 studies | 44% ± 3% | |
oligodendrocyte | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1696.50 | 653 / 653 | 99% | 6.32 | 601 / 605 |
brain | 100% | 3680.49 | 2630 / 2642 | 100% | 6.03 | 703 / 705 |
adrenal gland | 100% | 1694.75 | 258 / 258 | 99% | 8.52 | 227 / 230 |
kidney | 100% | 1336.20 | 89 / 89 | 98% | 4.87 | 885 / 901 |
prostate | 100% | 852.98 | 245 / 245 | 98% | 2.63 | 491 / 502 |
intestine | 100% | 1282.42 | 965 / 966 | 98% | 4.17 | 515 / 527 |
stomach | 100% | 1149.31 | 359 / 359 | 98% | 4.14 | 279 / 286 |
pancreas | 97% | 549.70 | 318 / 328 | 99% | 5.23 | 176 / 178 |
breast | 100% | 1154.02 | 459 / 459 | 93% | 3.43 | 1043 / 1118 |
lung | 100% | 1264.17 | 576 / 578 | 93% | 3.33 | 1070 / 1155 |
esophagus | 100% | 714.41 | 1443 / 1445 | 91% | 3.60 | 167 / 183 |
skin | 96% | 845.32 | 1745 / 1809 | 93% | 4.46 | 441 / 472 |
ovary | 99% | 820.06 | 178 / 180 | 87% | 2.59 | 375 / 430 |
uterus | 100% | 949.46 | 170 / 170 | 85% | 2.57 | 390 / 459 |
bladder | 100% | 946.10 | 21 / 21 | 84% | 3.04 | 421 / 504 |
liver | 99% | 624.58 | 224 / 226 | 75% | 1.92 | 303 / 406 |
adipose | 100% | 1094.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1320.71 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 737.10 | 1312 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 5.27 | 77 / 80 |
heart | 89% | 433.38 | 767 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 2.26 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 76% | 2.73 | 22 / 29 |
muscle | 67% | 272.04 | 540 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 440.41 | 545 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZFYVE28 |
Protein name | Zinc finger FYVE-type containing 28 Lateral signaling target protein 2 homolog (hLst2) (Zinc finger FYVE domain-containing protein 28) ZFYVE28 protein (Zinc finger FYVE-type containing 28) |
Synonyms | LST2 KIAA1643 |
Description | FUNCTION: Negative regulator of epidermal growth factor receptor (EGFR) signaling. Acts by promoting EGFR degradation in endosomes when not monoubiquitinated. . |
Accessions | ENST00000515169.5 [Q9HCC9-8] Q9HCC9 D6RID3 ENST00000508184.5 ENST00000509171.5 [Q9HCC9-7] ENST00000503000.1 [Q9HCC9-6] ENST00000511071.5 [Q9HCC9-2] ENST00000515312.5 [Q9HCC9-3] ENST00000508471.5 Q49AA1 ENST00000290974.7 [Q9HCC9-1] |